Evidence map›Paper›PMID 36241752›Full record

ArticleAbdominal radiology (New York)2023

Postoperative surveillance of pancreatic ductal adenocarcinoma (PDAC) recurrence: practice pattern on standardized imaging and reporting from the society of abdominal radiology disease focus panel on PDAC.

Linda C Chu, Zhen J Wang, Avinash Kambadakone, Elizabeth M Hecht, Jin He, Amol K Narang, Daniel A Laheru, Hina Arif-Tiwari, Priya Bhosale, Candice W Bolan and 20 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Abdominal radiology (New York), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Parametric mapping of dynamicCancer imaging : the official publication of the International Cancer Imaging Society · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Linda C ChuThe Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA. lindachu@jhmi.edu.ORCID 0000-0001-9729-2756
Zhen J WangDepartment of Radiology, University of California San Francisco School of Medicine, San Francisco, CA, USA.
Avinash KambadakoneDepartment of Radiology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, USA.
Elizabeth M HechtDepartment of Radiology, Weill Cornell Medicine, New York, NY, USA.
Jin HeDepartment of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Amol K NarangDepartment of Radiation Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Daniel A LaheruDepartment of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Hina Arif-TiwariDepartment of Medical Imaging, University of Arizona, Tuscon, AZ, USA.
Priya BhosaleDepartment of Radiology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Candice W BolanDepartment of Radiology, Mayo Clinic, Jacksonville, FL, USA.
Olga R BrookDepartment of Radiology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Abraham F BezuidenhoutDepartment of Radiology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Richard K G DoDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Samuel J GalganoDepartment of Radiology, University of Alabama at Birmingham School of Medicine, Birmingham, AL, USA.
Ajit H GoenkaDepartment of Radiology, Mayo Clinic, Rochester, MN, USA.
Alexander R GuimaraesDepartment of Diagnostic Radiology, Oregon Health & Science University, Portland, OR, USA.
David M HoughDepartment of Radiology, Mayo Clinic, Rochester, MN, USA.
Naveen KulkarniDepartment of Radiology, Medical College of Wisconsin & Froedtert Health, Milwaukee, WI, USA.
Ott LeDepartment of Radiology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Lyndon LukDepartment of Radiology, Columbia University Irving Medical Center, New York, NY, USA.
Lorenzo MannelliIstituto di Ricovero e Cura a Carattere Scientifico (IRCCS) SDN, Naples, Italy.
Michael RosenthalDepartment of Imaging, Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA.
Guillermo SangsterDepartment of Radiology, Ochsner Louisiana State University Health Shreveport, Shreveport, LA, USA.
Zarine K ShahDepartment of Radiology, Ohio State University Wexner Medical Center, Columbus, OH, USA.
Erik V SoloffDepartment of Radiology, University of Washington, Seattle, WA, USA.
Parag P TolatDepartment of Radiology, Medical College of Wisconsin & Froedtert Health, Milwaukee, WI, USA.
Marc ZinsDepartment of Radiology, Hôpital Paris Saint Joseph, Paris, France.
Elliot K FishmanThe Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Eric P TammDepartment of Radiology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Atif ZaheerThe Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Funding

Circulating Biomarker Consortium for Pancreatic Cancer Early DetectionU01CA210171 · NCI · DANA-FARBER CANCER INST · PI Michael H. Rosenthal, Brian Matthew Wolpin · 2016 to 2026
$8.7M
Optimizing Pancreatic Cancer Management with Next Generation Imaging and Liquid BiopsyR01CA256969 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Eric Collisson, Ajit Harishkumar Goenka · 2021 to 2026
$3.1M
Quantitative In Vivo 68Ga-Fibroblast-Activation-Protein-Inhibitors (FAPI)-46 PET Imaging of Cancer-Associated Fibroblasts (CAFs) in Pancreatic Ductal Adenocarcinoma (PDA)R01CA272628 · NCI · MAYO CLINIC ROCHESTER · PI GOENKA, AJIT HARISHKUMAR · 2022 to 2025
$2.5M
NCI NIH HHS R01 CA256969NCI NIH HHS R01 CA272628NCI NIH HHS U01 CA210171
6 · The paper itself

Abstract

purposeSurgical resection is the only potential curative treatment for patients with pancreatic ductal adenocarcinoma (PDAC), but unfortunately most patients recur within 5 years of surgery. This article aims to assess the practice patterns across major academic institutions and develop consensus recommendations for postoperative imaging and interpretation in patients with PDAC.

methodsThe consensus recommendations for postoperative imaging surveillance following PDAC resection were developed using the Delphi method. Members of the Society of Abdominal Radiology (SAR) PDAC Disease Focused Panel (DFP) underwent three rounds of surveys followed by live webinar group discussions to develop consensus recommendations.

resultsSignificant variations currently exist in the postoperative surveillance of PDAC, even among academic institutions. Differentiating common postoperative inflammatory and fibrotic changes from tumor recurrence remains a diagnostic challenge, and there is no reliable size threshold or growth rate of imaging findings that can provide differentiation. A new liver lesion or peritoneal nodule should be considered suspicious for tumor recurrence, and the imaging features should be interpreted in the appropriate clinical context (e.g., CA 19-9, clinical presentation, pathologic staging).

conclusionPostoperative imaging following PDAC resection is challenging to interpret due to the presence of confounding postoperative inflammatory changes. A standardized reporting template for locoregional findings and report impression may improve communication of relaying risk of recurrence with referring providers, which merits validation in future studies.

Indexed as

Carcinoma, Pancreatic DuctalGastrointestinal DiseasesPancreatic NeoplasmsRadiologyHumansNeoplasm Recurrence, LocalTomography, X-Ray ComputedCTMRIPancreatic ductal adenocarcinomaRecurrence

Identifiers

PMID36241752
PMCPMC12287877

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.